Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.

New adenosine derivatives have been synthesized and tested as putative agonists of adenosine receptors. Compounds 2-6 derive from the introduction of several types of substituents (electron donating, electron withdrawing, and halogens) in the para-position of the phenyl ring of the parent compound 1, and compound 7 lacks the hydroxyl group of amino alcohol 1. In radioligand binding assays using recombinant human A(1), A(2A), A(2B), and A(3) receptors, all compounds showed very low or negligible affinity for A(1) and A(2B) receptors but compounds 3, 5, and 7 displayed a remarkably potent affinity for the A(2A) receptor with K(i) values of 1-5 nM. Bromo derivative 3 displayed a selectivity A(1)/A(2A) = 62 and A(3)/A(2A) = 16 whereas the presence of a hydroxyl group (compound 5) improved the selectivity of A(1)/A(2A) and A(3)/A(2A) to 120- and 28-fold, respectively. When the methoxy derivative 4 lacks the hydroxyl group on the side chain (compound 7), the binding affinity for A(2A) is increased to 1 nM, improving selectivity ratios to 356- and 100-fold against A(1) and A(3), respectively. In Chinese hamster ovary cells transfected with human A(2A) and A(2B) receptors, most compounds showed a remarkable activity for the A(2A) receptor, except chloro derivative 2, with EC(50) values ranging from 1.4 to 8.8 nM. The compounds behaved as good A(2A) agonists, and all were more selective than 5'-(N-ethylcarboxamino)adenosine (NECA), with A(2B)/A(2A) ratios of cAMP accumulation ranging from 48 for compound 2 to 666 for compound 7 while the corresponding A(2B)/A(2A) ratio for NECA was only 9. Compounds 1, 3, 5, and 7 also displayed higher selectivities than NECA up to 100-fold in isolated aortas of rat and guinea pig. In guinea pig tracheal rings precontracted by carbachol, compounds 2 and 4 were more potent than adenosine (100-fold) and NECA (10-fold), whereas compounds 1 and 7 displayed similar effects to NECA. Pretreatment of the tracheal rings with A(2), A(2A), and A(2B) receptor antagonists 3,7-dimethyl-l-propargylxanthine, 8-(3-chlorostyryl)caffeine, and alloxazine produced a marked inhibition of the tracheal relaxations induced by compounds 1, 2, and 4, but none of the compounds showed selectivity toward any of the adenosine receptors.

[1]  A NEW GENERAL SYNTHESIS OF 2-AMINO ALCOHOLS , 1954 .

[2]  E. Cherbuliez,et al.  Une nouvelle synthèse de l'oxytocine , 1955 .

[3]  R. R. Schmidt,et al.  Riburonsäurederivate zur gezielten Veränderung der Ribose , 1974 .

[4]  R F Bruns,et al.  Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. , 1980, Canadian journal of physiology and pharmacology.

[5]  C. Stanfield,et al.  Synthesis of protected amino alcohols: a comparative study , 1981 .

[6]  J. Yoshimura,et al.  Synthesis of four stereoisomers of 4-amino-2-(hydroxymethyl)tetrahydrofuran-4-carboxylic acid , 1982 .

[7]  Synthesis and biological evaluation of sparsomycin analogues. , 1983, Journal of medicinal chemistry.

[8]  Chi‐Huey Wong,et al.  Enzyme-catalyzed irreversible formation of peptides containing D-amino acids , 1986 .

[9]  J. Plattner,et al.  A synthesis of protected aminoalkyl epoxides from .alpha.-amino acids , 1987 .

[10]  K. Klotz,et al.  2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors. , 1988, European journal of pharmacology.

[11]  Amino alcohols as C-terminal protecting groups in peptide synthesis , 1988 .

[12]  Synthesis and beta-adrenergic antagonism of 2-(aryloxy)-1-(2-piperidyl)ethanols. , 1988, Journal of medicinal chemistry.

[13]  G. Ghai,et al.  2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands. , 1990, Journal of medicinal chemistry.

[14]  K. Jacobson,et al.  Novel therapeutics acting via purine receptors. , 1991, Biochemical pharmacology.

[15]  H. Schäfer,et al.  Oxidation of partially protected carbohydrates at the nickel hydroxide electrode , 1991 .

[16]  Y. Salomon.  Cellular responsiveness to hormones and neurotransmitters: conversion of [3H]adenine to [3H]cAMP in cell monolayers, cell suspensions, and tissue slices. , 1991, Methods in enzymology.

[17]  Electroorganic Synthesis. Part 47. Oxidation of Partially Protected Carbohydrates at the Nickel Hydroxide Electrode. , 1991 .

[18]  K. Klotz,et al.  2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. , 1992, Journal of medicinal chemistry.

[19]  M. Ueeda,et al.  2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators. , 1992, Journal of medicinal chemistry.

[20]  S. Hourani,et al.  Adenosine receptor subtypes. , 1993, Trends in pharmacological sciences.

[21]  J. Chern,et al.  Doridosine derivatives: binding at adenosine receptors and in vivo effects. , 1993, European journal of pharmacology.

[22]  A. G. Graham,et al.  Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action. , 1994, Journal of medicinal chemistry.

[23]  P P Humphrey,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. , 1994, Pharmacological reviews.

[24]  E. De Clercq,et al.  An epimer of 5'-noraristeromycin and its antiviral properties. , 1994, Journal of medicinal chemistry.

[25]  A comparison of A2 adenosine receptor‐induced cyclic AMP generation in cerebral cortex and relaxation of pre‐contracted aorta , 1994, British journal of pharmacology.

[26]  K. Jacobson,et al.  Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. , 1995, Journal of medicinal chemistry.

[27]  K. Jacobson,et al.  Behavioral Effects of Adenosine Receptor stimulation , 1995 .

[28]  J. Kobe,et al.  Preparation and Utility of 5-β-D-Ribofuranosyl-2H-tetrazole as a Key Synthon for C-Nucleoside Synthesis. , 1995 .

[29]  Stephen P. H. Alexander,et al.  Adenosine receptor‐mediated relaxation of guinea‐pig precontracted, isolated trachea , 1995, British journal of pharmacology.

[30]  D. Jenkinson,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. , 1995, Pharmacological reviews.

[31]  Synthesis of a Vicinal Tricarbonyl Amide Derivative of L-Phenylalanine. , 1996, The Journal of organic chemistry.

[32]  J. Mendoza,et al.  Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A. , 1996, Journal of medicinal chemistry.

[33]  S. Hourani,et al.  Activation of multiple sites by adenosine analogues in the rat isolated aorta , 1996, British journal of pharmacology.

[34]  Synthesis and Protein Kinase C Inhibitory Activities of Acyclic Balanol Analogues That are Highly Selective for Protein Kinase C Over Protein Kinase A. , 1997 .

[35]  G. Martin,et al.  A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists. , 1997, Journal of medicinal chemistry.

[36]  Vimal,et al.  A convenient and mild procedure for the reduction of amino acids using amberlyst 15-NaBH4-LiCl , 1998 .

[37]  A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists. , 1998, Nucleosides & nucleotides.

[38]  M. McVey,et al.  Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. , 1998, The Journal of pharmacology and experimental therapeutics.

[39]  Effective and Mild Method for Preparation of Optically Active α‐Amino Aldehydes via TEMPO Oxidation. , 1998 .

[40]  B. Snider,et al.  Total Synthesis of (−)-FR901483 , 1999 .

[41]  N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. , 1999 .

[42]  M. McVey,et al.  Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. , 1999, Journal of cardiovascular pharmacology.

[43]  F. Campos,et al.  An efficient enantioselective synthesis of (R,R)-formoterol, a potent bronchodilator, using lipases , 2000 .

[44]  A. IJzerman,et al.  N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor. , 2000, Journal of medicinal chemistry.

[45]  C. Müller.  Adenosine receptor ligands-recent developments part I. Agonists. , 2000 .

[46]  I. Chen,et al.  A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes. , 2000, General pharmacology.

[47]  Efficient Synthesis of Chiral Isoquinoline and Pyrido[1,2-b]-isoquinoline Derivatives via Intramolecular Heck Reactions , 2001 .

[48]  A. IJzerman,et al.  2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor. , 2002, Journal of medicinal chemistry.